Probiotic Bifidobacterium lactis V9 attenuates hepatic steatosis and inflammation in rats with non-alcoholic fatty liver disease

Both steatosis and inflammation are key pathological events in the progression of non-alcoholic fatty liver disease (NAFLD). Probiotics are beneficial for the prevention and treatment of NAFLD. Bifidobacterium animalis subsp. lactis V9 (V9) is a newly isolated strain with favorable probiotic propert...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Yan, Liu, Chunyan, Zhao, Shimin, Wang, Xinxu, Wang, Jinling, Zhang, Heping, Wang, Yuzhen, Zhao, Guofen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7260323/
https://www.ncbi.nlm.nih.gov/pubmed/32472368
http://dx.doi.org/10.1186/s13568-020-01038-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7260323/
https://www.ncbi.nlm.nih.gov/pubmed/32472368
http://dx.doi.org/10.1186/s13568-020-01038-y

Ejemplares similares